BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10481943)

  • 1. Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation.
    Han S; Park K; Kim HY; Lee MS; Kim HJ; Kim YD
    Breast Cancer Res Treat; 1999 May; 55(2):161-7. PubMed ID: 10481943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.
    Pohl G; Rudas M; Dietze O; Lax S; Markis E; Pirker R; Zielinski CC; Hausmaninger H; Kubista E; Samonigg H; Jakesz R; Filipits M
    J Clin Oncol; 2003 Oct; 21(19):3594-600. PubMed ID: 14512390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
    Tsihlias J; Kapusta LR; DeBoer G; Morava-Protzner I; Zbieranowski I; Bhattacharya N; Catzavelos GC; Klotz LH; Slingerland JM
    Cancer Res; 1998 Feb; 58(3):542-8. PubMed ID: 9458103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer.
    Han S; Park K; Bae BN; Kim KH; Kim HJ; Kim YD; Kim HY
    J Surg Oncol; 2003 Aug; 83(4):241-7. PubMed ID: 12884237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients.
    Ploner F; Jakesz R; Hausmaninger H; Kolb R; Stierer M; Fridrik M; Steindorfer P; Gnant M; Haider K; Mlineritsch B; Tschurtschenthaler G; Steger G; Seifert M; Kubista E; Samonigg H;
    Onkologie; 2003 Apr; 26(2):115-9. PubMed ID: 12771518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-II mRNA expression in breast cancer: predictive value and relationship to other prognostic factors.
    Fiore E; Campani D; Muller I; Belardi V; Giustarini E; Rossi G; Pinchera A; Giani C
    Int J Biol Markers; 2010; 25(3):150-6. PubMed ID: 20677165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy.
    Pohl G; Rudas M; Taucher S; Stranzl T; Steger GG; Jakesz R; Pirker R; Filipits M
    Breast Cancer Res Treat; 2003 Mar; 78(1):97-103. PubMed ID: 12611462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated expression of p27(Kip1) in human breast cancers.
    Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
    Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients.
    Porter PL; Malone KE; Heagerty PJ; Alexander GM; Gatti LA; Firpo EJ; Daling JR; Roberts JM
    Nat Med; 1997 Feb; 3(2):222-5. PubMed ID: 9018243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma.
    Ohtani M; Isozaki H; Fujii K; Nomura E; Niki M; Mabuchi H; Nishiguchi K; Toyoda M; Ishibashi T; Tanigawa N
    Cancer; 1999 Apr; 85(8):1711-8. PubMed ID: 10223564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.
    Specht K; Harbeck N; Smida J; Annecke K; Reich U; Naehrig J; Langer R; Mages J; Busch R; Kruse E; Klein-Hitpass L; Schmitt M; Kiechle M; Hoefler H
    Breast Cancer Res Treat; 2009 Nov; 118(1):45-56. PubMed ID: 18925433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas.
    Oh YH; Park CK
    J Korean Med Sci; 2000 Aug; 15(4):399-406. PubMed ID: 10983687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.
    Catzavelos C; Bhattacharya N; Ung YC; Wilson JA; Roncari L; Sandhu C; Shaw P; Yeger H; Morava-Protzner I; Kapusta L; Franssen E; Pritchard KI; Slingerland JM
    Nat Med; 1997 Feb; 3(2):227-30. PubMed ID: 9018244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of p27Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells.
    Sgambato A; Zhang YJ; Ciaparrone M; Soh JW; Cittadini A; Santella RM; Weinstein IB
    Cancer Res; 1998 Aug; 58(15):3448-54. PubMed ID: 9699679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
    Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
    Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.
    Han W; Han MR; Kang JJ; Bae JY; Lee JH; Bae YJ; Lee JE; Shin HJ; Hwang KT; Hwang SE; Kim SW; Noh DY
    BMC Cancer; 2006 Apr; 6():92. PubMed ID: 16608533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p27kip1 in breast cancer and its prognostic significance.
    Barnes A; Pinder SE; Bell JA; Paish EC; Wencyk PM; Robertson JF; Elston CW; Ellis IO
    J Pathol; 2003 Nov; 201(3):451-9. PubMed ID: 14595757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.